Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

423.97
Delayed Data
As of Feb 15
 +9.00 / +2.17%
Today’s Change
281.89
Today|||52-Week Range
431.32
+13.51%
Year-to-Date

Today’s Trading

Previous close414.97
Today’s open417.97
Day’s range415.72 - 424.39
Volume700,044
Average volume (3 months)762,629
Market cap$44.9B
Data as of 3:59pm ET, 02/15/2019

Growth & Valuation

Earnings growth (last year)+42.53%
Earnings growth (this year)+0.32%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+14.28%
P/E ratio19.9
Price/Sales6.39
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.99+1.37%
VRTXVertex Pharmaceutica...+2.35+1.27%
ZTSZoetis Inc+2.11+2.26%
ALXNAlexion Pharmaceutic...+3.49+2.77%
Data as of 4:15pm ET, 02/15/2019

Financials

Next reporting dateMay 6, 2019
EPS forecast (this quarter)$5.28
Annual revenue (last year)$6.7B
Annual profit (last year)$2.4B
Net profit margin36.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts